共 18 条
[3]
Czarska-thorley D, NTR
[5]
FDA, NTR
[9]
Tofacitinib for the treatment of moderately to severely active ulcerative colitis: a systematic review, network meta-analysis and economic evaluation
[J].
BMJ OPEN GASTROENTEROLOGY,
2019, 6 (01)